Merit Medical Systems, Inc. (MMSI) announced positive six-month findings from the single-arm Arteriovenous Graft (AVG) cohort of its WRAPSODY Arteriovenous Access Efficacy (WAVE) pivotal trial yesterday. The WAVE trial was designed to assess the efficacy and safety of the WRAPSODY device.The WRAPSODY Cell-Impermeable Endoprosthesis is currently not approved or available for commercial distribution in the United States. It may also not be approved or available for sale or use in other countries. However, the ...

Investors seek growth stocks to capitalize on above-average growth in financials that help these securities grab the market's attention and produce exceptional returns. However, it isn't easy to find a great growth stock.In addition to volatility, these stocks carry above-average risk by their very nature. Also, one could end up losing from a stock whose growth story is actually over or nearing its end.However, the task of finding cutting-edge growth stocks is made easy with the help of the Zacks Growth Sty ...

Merit Medical Systems, Inc. (MMSI) witnessed strong momentum in the year-to-date period. Shares of the company have rallied 37.9% compared with the industry’s growth of 3.6%. The S&P 500 composite has risen 24% in the same period.With healthy fundamentals and strong growth opportunities, this Zacks Rank #2 (Buy) company appears to be a solid wealth creator for its investors at the moment.Merit Medical specializes in providing products for peripheral and cardiac interventions, targeting conditions in interve ...

Have you been paying attention to shares of Merit Medical (MMSI) ? Shares have been on the move with the stock up 8.8% over the past month. The stock hit a new 52-week high of $102.88 in the previous session. Merit Medical has gained 34.2% since the start of the year compared to the 4% move for the Zacks Medical sector and the 4.3% return for the Zacks Medical - Dental Supplies industry.What's Driving the Outperformance?The stock has a great record of positive earnings surprises, as it hasn't missed our ear ...

Investors seek growth stocks to capitalize on above-average growth in financials that help these securities grab the market's attention and produce exceptional returns. However, it isn't easy to find a great growth stock.By their very nature, these stocks carry above-average risk and volatility. Moreover, if a company's growth story is over or nearing its end, betting on it could lead to significant loss.However, the Zacks Growth Style Score (part of the Zacks Style Scores system), which looks beyond the tr ...

SOUTH JORDAN, Utah, Nov. 01, 2024 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader in healthcare technology, today reported that it has completed the acquisition of Cook Medical’s lead management portfolio. The purchase consideration consisted of a cash payment of approximately $210 million and the assumption of certain liabilities. Merit funded the acquisition payment through a combination of cash on hand and borrowings under its long-term credit facility. “We are pleased to ...

Merit Medical Systems, Inc. (MMSI) reported third-quarter 2024 adjusted earnings per share (EPS) of 86 cents, up 21.1% from the year-ago quarter. The bottom line surpassed the Zacks Consensus Estimate by 7.5%.GAAP EPS for the quarter was 48 cents, up 9.1% year over year.Find the latest EPS estimates and surprises on Zacks Earnings Calendar.MMSI’s Revenue DetailsRevenues grossed $339.8 million in the reported quarter, up 7.8% year over year. The metric topped the Zacks Consensus Estimate by 1.4%.Total revenu ...

Merit Medical Systems, Inc. (NASDAQ:MMSI) Q3 2024 Earnings Conference Call October 30, 2024 5:00 PM ET Company Participants Fred Lampropoulos - Founder, Chairman & Chief Executive Officer Brian Lloyd - Chief Legal Officer & Corporate Secretary Joe Wright - President Raul Parra - Chief Financial Officer Conference Call Participants John Young - Canaccord Jayson Bedford - Raymond James Jason Bednar - Piper Sandler David Rescott - R.W. Baird Mike Matson - Needham Craig Bijou - Bank of America Securities Jim Si ...

Merit Medical (MMSI) reported $339.85 million in revenue for the quarter ended September 2024, representing a year-over-year increase of 7.8%. EPS of $0.86 for the same period compares to $0.75 a year ago. View all Key Company Metrics for Merit Medical here>>> The reported revenue represents a surprise of +1.44% over the Zacks Consensus Estimate of $335.02 million. With the consensus EPS estimate being $0.80, the EPS surprise was +7.50%. While investors closely watch year-over-year changes in headline numbe ...

Third Quarter 2024 Results 1 Merit Medical Investor Call October 30, 2024 Fred Lampropoulos Chairman and CEO Raul Parra CFO m | --- | --- | |----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ...